Handbook of HER2-Targeted Agents in Breast Cancer.
ثبت نشده
چکیده
As known, to finish this book, you may not need to get it at once in a day. Doing the activities along the day may make you feel so bored. If you try to force reading, you may prefer to do other entertaining activities. But, one of concepts we want you to have this book is that it will not make you feel bored. Feeling bored when reading will be only unless you don't like the book. handbook of her2 targeted agents in breast cancer really offers what everybody wants.
منابع مشابه
Development of RNA aptamers as molecular probes for HER2+ breast cancer study using cell-SELEX
Objective(s): Development of molecules that specifically recognize cancer cells is one of the major areas in cancer research. Human epidermal growth factor receptor 2 (HER2) is specifically expressed on the surface of breast cancer cells. HER2 is associated with an aggressive phenotype and poor prognosis. In this study we aimed to isolate RNA aptamers that specifically bind to HER2 overexpressi...
متن کاملIdentification of Prognostic Genes in Her2-enriched Breast Cancer by Gene Co-Expression Net-work Analysis
Introduction: HER2-enriched subtype of breast cancer has a worse prognosis than luminal subtypes. Recently, the discovery of targeted therapies in other groups of breast cancer has increased patient survival. The aim of this study was to identify genes that affect the overall survival of this group of patients based on a systems biology approach. Methods: Gene expression data and clinical infor...
متن کاملTargeted therapy in her2-positive metastatic breast cancer: a review of the literature.
Breast tumours positive for her2 (human epidermal growth factor receptor 2) represent approximately 20% of all breast cancer cases and are associated with an aggressive natural history. The advent of targeted anti-her2 therapies has dramatically improved disease control and survival in patients with metastatic her2-positive breast cancer. Targeted agents are now considered the standard of care ...
متن کاملAdvances in treating HER2-positive breast cancer: an interview with Sunil Verma
In this podcast, we talk to Dr Sunil Verma about the evolution of HER2 as a therapeutic target in breast cancer, and about how targeted therapy has revolutionized breast cancer treatment. We also discuss new agents in clinical development and the ways in which advances in treating HER2-positive breast cancer can be used to inform treatment decisions in other areas of medicine.
متن کاملThe efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis.
BACKGROUND The addition of HER2-targeted agents to standard treatment has been shown to improve outcomes for HER2 positive metastatic breast cancer patients. We undertook a meta-analysis to evaluate the efficacy of HER2-targeted therapy in addition to standard treatment in metastatic breast cancer patients. PATIENTS AND METHODS Eligible trials were randomised controlled trials (RCTs) comparin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Anticancer research
دوره 36 8 شماره
صفحات -
تاریخ انتشار 2016